Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline in Adult Smokers With ADHD
NCT00907218Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of varenicline in attention deficit hyperactivity disorder (ADHD), nicotine dependence, sponsored by Massachusetts General Hospital. Started Apr 2009; status: terminated.
02
Drugs
varenicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)nicotine dependence
Beyond the preview
Go deeper on NCT00907218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907218.